Eisai Co., Ltd. (CEO: Haruo Naito, “Eisai”) and Purdue Pharma L.P. (President and CEO: Craig Landau, MD “Purdue Pharma”) today announced that they will present data on their investigational sleep-wake regulation agent lemborexant (development code: E2006), in an oral presentation at the 43rd Annual Meeting of the Japanese Society of Sleep Research (JSSR), July 11-13, Sapporo, Japan Read More »

Eisai Co., Ltd. (CEO: Haruo Naito, “Eisai”) and Purdue Pharma L.P. (President and CEO: Craig Landau, “Purdue Pharma”) today presented the results of two key Phase 1 clinical studies of their investigational sleep/wake regulation agent lemborexant at the 32nd Annual Meeting of the Associated Professional Sleep Societies (SLEEP 2018), June 2-6, Baltimore, MD. Lemborexant is currently being studied for the potential treatment of multiple sleep disorders. Read More »

Aetna’s recently announced expansion efforts in Wellesley, Mass., not only demonstrate the company’s commitment to the local community, but to transforming the consumer health experience. Read More »

As part of Aetna’s commitment to enhancing access to evidence-based addiction treatment options for its members, medication-assisted treatment (MAT) is available for those with opioid use disorder. Read More »

Just announced that John Renger, Ph.D., has been appointed Vice President, Head of Research & Development and Regulatory Affairs. He will be based in Stamford, Connecticut and report directly to President and CEO Craig Landau, MD. Read More »

Aetna’s continuing work on helping combat the opioid epidemic includes a study suggesting the strength of the drug might not be the best predictor of misuse. Read More »

The Aetna Foundation announced the next step in its funding initiative to fight the ongoing opioid epidemic with a $1 million grant to the Pennsylvania Department of Health. Read More »

Boehringer Ingelheim announced that their Phase II Alzheimer’s disease trials with investigational compound BI 409306 had not met their efficacy endpoints and plans for further trials with BI 409306 in AD will therefore not be pursued. Read More »

Pediatric-onset hypophosphatasia, an extremely rare metabolic disease affecting bone structure and strength, came into sharper focus recently when Alexion Pharmaceuticals won funding for its Strensiq medication from two sources via a managed access agreement. Read More »

Cigna and CVS Health have launched Cigna HealthWorks, a partnership that brings Cigna benefits to CVS Pharmacy and CVS MinuteClinic retail health care centers. Read More »

Purdue Pharma's Colace product line and Senokot tablets will now come with new packaging. Read More »

Purdue Pharma L.P.'s Maria Barton has been promoted from deputy general counsel to general counsel. Read More »

Josie Martin has been named vice president of corporate affairs and communications for Purdue Pharma LP. Read More »

Purdue Pharma LP's Carrie Chomiak will be stepping up into a substantial business role as lead of over-the-counter product franchise for brands including Betadine microbicide antiseptics, Slow-Mag magnesium chloride supplements, Senokot laxative and Colace stool softener. Read More »

The American Society of Health-System Professionals recently announced that the United States updated the Common Rule, a federal regulation that supports research involving human subjects. Read More »

Teaming up to enhance North Carolina’s public health outcomes, Purdue Pharma of Stamford, Connecticut; nationwide Project Lazarus; and Safe Kids North Carolina recently entered a three-way collaboration via the North Carolina Disposal Initiative (NCDI). Read More »

Shionogi Inc. and Purdue Pharma L.P.'s Symproic 0.2 mg tablets C-II have been approved by the U.S. Food and Drug Administration for use as a once-daily oral peripherally-acting mu-opioid receptor antagonist medication in treating opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain. Read More »

The recent 2017 Economic Report on Pharmacies and Pharmacy Benefit Managers by Drug Channels named the top 15 U.S. Pharmacies of 2016.  Read More »

Purdue Pharma LP has named Margaret Feltz vice president and chief ethics/compliance officer, reporting to President and CEO Mark Timney. Read More »

Precision for Value has named Dr. Maureen Hennessey, senior vice president and director of quality and population health systems, to the National Quality Forum’s Medicaid Innovation Accelerator Project 2016-2017. Read More »